000724554 000__ 03383cam\a2200505Ii\4500
000724554 001__ 724554
000724554 005__ 20230306140538.0
000724554 006__ m\\\\\o\\d\\\\\\\\
000724554 007__ cr\cn\nnnunnun
000724554 008__ 141201s2015\\\\sz\a\\\\o\\\\\000\0\eng\d
000724554 019__ $$a900314376$$a908086287
000724554 020__ $$a9783319120096$$qelectronic book
000724554 020__ $$a3319120093$$qelectronic book
000724554 020__ $$z9783319120089
000724554 0247_ $$a10.1007/978-3-319-12009-6$$2doi
000724554 035__ $$aSP(OCoLC)ocn897115867
000724554 035__ $$aSP(OCoLC)897115867$$z(OCoLC)900314376$$z(OCoLC)908086287
000724554 040__ $$aN$T$$beng$$erda$$epn$$cN$T$$dYDXCP$$dOCLCO$$dGW5XE$$dCOO$$dN$T$$dIDEBK$$dEBLCP
000724554 049__ $$aISEA
000724554 050_4 $$aQR46.5$$b.M36 2015
000724554 08204 $$a615.3/2939$$223
000724554 1001_ $$aMandal, Sikha,$$eauthor.
000724554 24510 $$aExtremophilic cyanobacteria for novel drug development$$h[electronic resource] /$$cSikha Mandal, Jnanendra Rath.
000724554 264_1 $$aCham :$$bSpringer,$$c2015.
000724554 300__ $$a1 online resource :$$billustrations.
000724554 336__ $$atext$$btxt$$2rdacontent
000724554 337__ $$acomputer$$bc$$2rdamedia
000724554 338__ $$aonline resource$$bcr$$2rdacarrier
000724554 347__ $$atext file$$bPDF$$2rda
000724554 4901_ $$aSpringerBriefs in Pharmaceutical Science & Drug Development,$$x1864-8118
000724554 5050_ $$a1 Introduction -- 2 Secondary Metabolites of Cyanobacteria and Drug Development -- 3 Glycoconjugates of Cyanobacteria and Potential Drug Development from them -- 4 Anticancer Drug Development from Cyanobacteria -- 5 Issues and Challenges of Drug Development from Cyanobacteria.
000724554 506__ $$aAccess limited to authorized users.
000724554 520__ $$aThis volume presents recent developments in the novel drug development and potential of extremophilic cyanobacteria. It discusses how these tiny organism originated, produce oxygen that leads to evolution of life on the earth, how their survival strategies in extreme climatic conditions lead to diverse metabolic pathways, and the opportunity to use them to develop novel drugs. The book is comprised of five chapters, starting with the origin of cyanobacteria, their survival strategies under extreme conditions, and their capabilities to change metabolic activities.The second chapter explores the different metabolic pathways found in cyanobacteria and examines advances in this field and recent techniques like MALDI-TOF imaging and metagenomics tools as well as in silico techniques for rapid screening of secondary metabolites. Further chapters cover the glycomics of cyanobacteria, anticancer drug development, and some issues and challenges of using cyanobacteria to develop drugs. Extremophilic Cyanobacteria For Novel Drug Development provides insight into future perspectives in drug development and is a key resource for students, researchers and professionals in pharmacy, medicinal chemistry, pharmacognosy biotechnology, biology, and academics.
000724554 650_0 $$aCyanobacteria$$xTherapeutic use.
000724554 650_0 $$aDrug development.
000724554 650_0 $$aPharmaceutical microbiology.
000724554 650_0 $$aExtreme environments$$xMicrobiology.
000724554 650_0 $$aMicrobial metabolites.
000724554 7001_ $$aRath, Jnanen,$$eauthor.
000724554 77608 $$iPrint version:$$z9783319120089
000724554 830_0 $$aSpringerBriefs in pharmaceutical science & drug development.
000724554 852__ $$bebk
000724554 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-319-12009-6$$zOnline Access$$91397441.1
000724554 909CO $$ooai:library.usi.edu:724554$$pGLOBAL_SET
000724554 980__ $$aEBOOK
000724554 980__ $$aBIB
000724554 982__ $$aEbook
000724554 983__ $$aOnline
000724554 994__ $$a92$$bISE